Powered by
-
BDX Stock Chart
Historical BDX Prices
Becton Dickinson Stock Analysis
Rating:
Total Grade:
Analysis Breakdown
| BDX Stock Grade: | |
| Fundamental Grade: | |
| Quantitative Grade: | |
| BDX Earnings | |
| Earnings Growth: | |
| Earnings Momentum: | |
| Earnings Surprises: | |
| Analyst Earnings Revisions: | |
| BDX Financial Information | |
| Sales Growth: | |
| Operating Margin Growth: | |
| Cash Flow: | |
| Return on Equity: | |
Becton Dickinson Stock: Weekly View
| This Week: | |
|---|---|
| Last Week: | |
| Two Weeks Ago: |
BDX Stock predictions, Articles, and Becton Dickinson News
- From InvestorPlace
- From the Web
-
10 Super Safe Growth Stocks for Long-Lasting Dividends - December 6, 2018
Not all dividend stocks are created equal. Here are the best dividend growth stocks to buy that have the potential to become long-term plays. Continue…
-
10 Blue-Chip Stocks to Buy for an Earnings Bump - October 23, 2018
Don't think for a minute that blue-chip stocks aren't capable of dishing out big moves, when the earnings news is compelling enough. Continue…
-
5 Healthcare Stocks to Buy for Complete Portfolio Wellness - October 10, 2018
Thanks to advancing technologies and a generally positive economy, healthcare stocks are back in the limelight. Continue…
-
5 Medical Device Stocks With Impressive Staying Power - September 13, 2018
Medical device stocks could be the best play in all of healthcare. Here are five of the best choices for any portfolio. Continue…
-
The 10 Most Expensive Stocks In The S&P 500 - January 24, 2018
These ten stocks are currently the most expensive stocks trading on the S&P 500 -- so buyer beware. Continue…
-
Stellar Metrics for Earnings Growth Keep Becton Dickinson & Co (BDX) a Strong Buy - December 12, 2017
Becton Dickinson & Co (NYSE:BDX) is a constituent of the 161 company Health Care Equipment & Supplies GICS industry group, which is part of the 782 company GICS Health Care sector. The market value of BDX is $50.1 billion which falls in the top 10% of its industry group. Portfolio Grader's current ranking for BDX puts it 17 among the 161 companies in this industry group, giving it a well above-average position; in the top decile of the sector with a ranking of 46 among the 782 companies in the sector, and number 268 in the nearly 5,000 company Portfolio Grader universe. Continue…
-
Superb Quant Score Makes Becton Dickinson & Co (BDX) a Strong Buy - December 5, 2017
Becton Dickinson & Co (NYSE:BDX) is ranked as a Strong Buy using Louis Navellier's approach to investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking BDX has had from Portfolio Grader for the last month. Continue…
-
Becton Dickinson & Co (BDX) a Strong Buy on Best-in-Class Quant Score - November 28, 2017
Becton Dickinson & Co (NYSE:BDX) is one of the 781 companies in the GICS Health Care sector, and a member of the 161 company Health Care Equipment & Supplies GICS industry group within this sector. The market value of BDX is $51.6 billion which places it in the top decile in its industry group. Currently, the stock's Portfolio Grader ranking places it 18 among the 161 companies in this industry group, placing it among the leaders; in the top decile of the sector with a ranking of 55 among the 781 companies in the sector, and number 301 in the nearly 5,000 company Portfolio Grader universe. Continue…
-
Becton Dickinson & Co (BDX) a Strong Buy on Stellar Earnings Growth - November 21, 2017
Becton Dickinson & Co (NYSE:BDX) is ranked as a Strong Buy using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. BDX has recently seen its Portfolio Grader rating upgraded from a Buy to a Strong Buy. Continue…
-
Exceptional Earnings Growth Metrics Raise Ranking of Becton Dickinson & Co (BDX) to Strong Buy - November 14, 2017
The current recommendation of Strong Buy for Becton Dickinson & Co (NYSE:BDX) is the result of using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The shares have been upgraded from a Buy to a Strong Buy in the last week. Continue…
